Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 64, Issue 8
Volume 64, Issue 8
15 April 2017
ISSN 1058-4838
EISSN 1537-6591

Volume 64, Issue 8, 15 April 2017

NEWS

Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages i–ii, https://doi.org/10.1093/cid/cix161

IN THE LITERATURE

Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages iii–iv, https://doi.org/10.1093/cid/cix051

ARTICLES AND COMMENTARIES

Iván Pelegrín and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 989–997, https://doi.org/10.1093/cid/cix005

Little is known regarding the optimal treatment of ventriculoperitoneal (VP) shunt infections in adults. VP shunt removal, particularly with a 2-stage replacement strategy when the patient is shunt dependent, remains the optimal choice of treatment and does not increase morbidity.

Stephan P. Keijmel and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 998–1005, https://doi.org/10.1093/cid/cix013

Cognitive-behavioral therapy is effective in reducing fatigue severity in patients with Q fever fatigue syndrome (QFS). Long-term treatment with doxycycline does not reduce fatigue severity in QFS patients compared to placebo and should not be advised.

Dami Collier and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1006–1016, https://doi.org/10.1093/cid/cix015

A community based, second-line treatment cohort of 102 subjects was followed monthly in community clinics with a total of 178 patient-years of follow-up; second-line virological failure was frequent in this setting.

Jesica A. Herrick and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1017–1025, https://doi.org/10.1093/cid/cix016

This study demonstrates that immune responses and side-effect profiles following diethylcarbamazine or ivermectin treatment of loiasis are similar. Changes in eosinophil counts and eosinophil activation posttreatment suggest that eosinophils play a key role in the posttreatment responses to both drugs.

Yu-Chung Chuang and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1026–1034, https://doi.org/10.1093/cid/cix024

Daptomycin displays a dose-dependent clinical response against vancomycin-resistant Enterococcus faecium bloodstream infection. A daptomycin dose of ≥9 mg/kg was associated with better patient survival than a dose of 7–9 mg/kg, followed by a dose of 6–7 mg/kg.

Susanna Naggie and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1035–1042, https://doi.org/10.1093/cid/cix025

SWIFT-C is an open-label, 2-cohort clinical trial that is assessing the safety and efficacy of 12 weeks of sofosbuvir plus ribavirin for treatment of acute hepatitis C virus in human immunodeficiency virus–infected patients. The relapse rate was high (41%), suggesting a need for better therapeutic options.

R. Matthew Chico and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1043–1051, https://doi.org/10.1093/cid/cix026

Compared to 0–1 dose of intermittent preventive treatment of malaria using sulfadoxine-pyrimethamine, ≥2 doses protects pregnant women against adverse birth outcomes attributable to malaria infection and to curable sexually transmitted and reproductive tract infections.

Adel Alrwisan and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1052–1058, https://doi.org/10.1093/cid/cix032

Despite the widespread use of quinolones ear drops, no studies have examined their adverse effect on the eardrum. Children receiving quinolone ear drops are 60% more likely to have eardrum perforations in comparison to those received neomycin ear drops.

Ruthiran Kugathasan and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1059–1065, https://doi.org/10.1093/cid/cix035

Among patients presenting with diverse neurological problems at a single center, cerebrospinal fluid discordance or escape was observed in 15% and was associated with diffuse white matter signal abnormalities on cranial magnetic resonance imaging.

Hazel C. Dobinson and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1066–1073, https://doi.org/10.1093/cid/cix042

The safe establishment of a protocol for a human challenge model for Salmonella Paratyphi A can be used to expedite the evaluation of novel vaccine candidates and provides insight into the clinical and immune response to paratyphoid infection.

John A. Branda and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1074–1080, https://doi.org/10.1093/cid/cix043

We evaluated 3 modified 2-tiered testing protocols for Lyme disease, which substitute noncomplex, objectively interpreted, inexpensive serologic assays for Western blotting. Compared with conventional 2-tiered testing, each modified protocol provided comparable or greater sensitivity in early disease and was comparably specific.

Lukas Stulik and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1081–1088, https://doi.org/10.1093/cid/cix055

Exposure of ventilated patients to antibiotics, often to several, does not efficiently reduce lower airway colonization by Staphylococcus aureus or progression to ventilator-associated tracheobronchitis or ventilator-associated pneumonia. Staphylococcus aureus competes with the normal respiratory flora during airway colonization.

Jason P. Burnham and Marin H. Kollef
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1089–1091, https://doi.org/10.1093/cid/cix060
L. Marije Hofstra and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1092–1097, https://doi.org/10.1093/cid/cix056

The prevalence of resistant HIV in Aruba has increased to alarming levels, compromising the WHO-recommended first-line regimen. As adequate surveillance as advocated by the WHO is limited, the Caribbean region could face an unidentified rise of NNRTI-resistant HIV.

Anne-Sophie Dugast and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1098–1104, https://doi.org/10.1093/cid/cix057

The evolution of broadly neutralizing antibodies (bNAbs) in spontaneous controllers of HIV appears in the setting of low but persistent viral replication, in the absence of significant viral diversity, but in the presence of a unique inflammatory signature.

Intira Jeannie Collins and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1105–1112, https://doi.org/10.1093/cid/cix063

One-third of the UK/Ireland national pediatric HIV cohort has transferred to adult care. Three-quarters of adolescents were on ART at transfer, of whom 74% were virologically suppressed <400 cps/mL. The prevalence of triple class resistance was 12%.

Annette H. Sohn and Rohan Hazra
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1113–1114, https://doi.org/10.1093/cid/cix068
Heidi M. Soeters and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1115–1122, https://doi.org/10.1093/cid/cix091

MenB-FHbp (factor H binding protein), a serogroup B meningococcal vaccine, was used to control a college outbreak. We investigated MenB-FHbp impact on nasopharyngeal meningococcal carriage, the primary source of meningococcal transmission. MenB-FHbp did not rapidly reduce meningococcal carriage or prevent serogroup B carriage acquisition.

BRIEF REPORTS

Judith Strymish and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1123–1125, https://doi.org/10.1093/cid/cix058
Daniel P. McQuillen and Steven K. Schmitt
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1126–1128, https://doi.org/10.1093/cid/cix062
Christiane S. Eberhardt and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1129–1132, https://doi.org/10.1093/cid/cix046

PHOTO QUIZ

Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Page 1133, https://doi.org/10.1093/cid/cix171

INVITED ARTICLE

CLINICAL PRACTICE

Debra A. Goff and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1134–1139, https://doi.org/10.1093/cid/cix065

The Joint Commission issued antimicrobial stewardship standards, consisting of 8 elements of performance, applicable to hospitals effective January 1, 2017. Little guidance exists on “how” to implement them. Real-world experience from established antimicrobial stewardship programs describes how hospitals can comply.

ANSWER TO THE PHOTO QUIZ

Maryam Mahmood and Mary J. Kasten
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1140–1141, https://doi.org/10.1093/cid/cix175

CORRESPONDENCE

Miriam Levi and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1142–1143, https://doi.org/10.1093/cid/cix107
Annette K. Regan and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1143–1144, https://doi.org/10.1093/cid/cix108
Jaan Peter Naktin
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Page 1144, https://doi.org/10.1093/cid/cix084
Melanie Uhde and others
Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Pages 1145–1146, https://doi.org/10.1093/cid/cix086

COVER

Clinical Infectious Diseases, Volume 64, Issue 8, 15 April 2017, Page NP, https://doi.org/10.1093/cid/cix054
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close